The Evidence Base
Post
Advancing real-world data research through the Innovation in Medical Evidence and Development Surveillance (IMEDS) program: an interview with Carla Rodriguez-Watson, Reagan-Udall Foundation for the FDA
Register with The Evidence Base for free to access this content
Already have an account? Sign in
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.